Dipyridamole Injection
Product Images NDC 0404-9852

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dipyridamole (NDC 0404-9852). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Chemical structure of Dipyridamole showing its molecular framework with nitrogen-containing rings and multiple hydroxyethyl substituents.*

FDA Label Image

Image1.jpg (Image1)

A data table listing drug-related adverse events with their incidence percentages. The adverse reactions include chest pain/angina pectoris, headache, dizziness, electrocardiographic abnormalities (ST-T changes, extrasystoles, tachycardia), hypotension, nausea, flushing, dyspnea, unspecified pain, blood pressure lability, hypertension, paresthesia, and fatigue.*

FDA Label Image

Label1.jpg (Label1)

Dipyridamole 5 mg/mL injection, USP single dose vial label showing 50 mg per 10 mL vial. The label includes instructions for intravenous use in myocardial imaging, storage conditions between 15 to 25°C, and warnings to keep out of children's reach and avoid freezing. Packaged by Henry Schein, Inc., Bastian, VA, with NDC 0404-9852-10 visible on the barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.